TY - JOUR
T1 - Antibody therapies for lymphoma in children
AU - de Zwart, Verena
AU - Gouw, Samantha C.
AU - Meyer-Wentrup, Friederike A. G.
PY - 2014/7/2
Y1 - 2014/7/2
N2 - This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the efficacy of antibody therapy for childhood lymphoma in terms of survival, response and relapse rates, compared with therapy not including antibody treatment. Furthermore, we aim to assess quality of life and the occurrence of adverse effects caused by antibody therapy treatment in children compared with therapy not including antibody treatment.
AB - This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the efficacy of antibody therapy for childhood lymphoma in terms of survival, response and relapse rates, compared with therapy not including antibody treatment. Furthermore, we aim to assess quality of life and the occurrence of adverse effects caused by antibody therapy treatment in children compared with therapy not including antibody treatment.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84969968719&origin=inward
U2 - https://doi.org/10.1002/14651858.CD011181
DO - https://doi.org/10.1002/14651858.CD011181
M3 - Review article
SN - 1469-493X
VL - 2014
JO - Cochrane Database of Systematic Reviews
JF - Cochrane Database of Systematic Reviews
IS - 7
M1 - CD011181
ER -